These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9171214)

  • 21. [Methodology and problems in the study of drugs of abuse in urine].
    Sieghart W
    Wien Klin Wochenschr; 1986 Jun; 98(13):411-6. PubMed ID: 2875564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drugs of abuse screening in the West Midlands: a 6 year retrospective survey of results.
    George S; Braithwaite RA
    Ann Clin Biochem; 1994 Sep; 31 ( Pt 5)():473-8. PubMed ID: 7832574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of drugs of abuse in urine of drivers involved in road accidents in France: a collaborative study.
    Marquet P; Delpla PA; Kerguelen S; Bremond J; Facy F; Garnier M; Guery B; Lhermitte M; Mathé D; Pelissier AL; Renaudeau C; Vest P; Seguela JP
    J Forensic Sci; 1998 Jul; 43(4):806-11. PubMed ID: 9670503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ONTRAK TESTCUP: a novel, on-site, multi-analyte screen for the detection of abused drugs.
    Towt J; Tsai SC; Hernandez MR; Klimov AD; Kravec CV; Rouse SL; Subuhi HS; Twarowska B; Salamone SJ
    J Anal Toxicol; 1995 Oct; 19(6):504-10. PubMed ID: 8926746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug abuse proficiency testing.
    Guerrant GO; Hall CT
    Clin Toxicol; 1977; 10(2):209-19. PubMed ID: 852242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive analysis of drugs of abuse in urine using disposable pipette extraction.
    Ellison ST; Brewer WE; Morgan SL
    J Anal Toxicol; 2009 Sep; 33(7):356-65. PubMed ID: 19796505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multiple-site laboratory evaluation of three on-site urinalysis drug-testing devices.
    Crouch DJ; Frank JF; Farrell LJ; Karsch HM; Klaunig JE
    J Anal Toxicol; 1998 Oct; 22(6):493-502. PubMed ID: 9788525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of RapiTest with Emit d.a.u. and GC-MS for the analysis of drugs in urine.
    Korte T; Pykäläinen J; Lillsunde P; Seppälä T
    J Anal Toxicol; 1997; 21(1):49-53. PubMed ID: 9013293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modification of screening immunoassays to detect sub-threshold concentrations of cocaine, cannabinoids, and opiates in urine: use for detecting maternal and neonatal drug exposures.
    Hattab EM; Goldberger BA; Johannsen LM; Kindland PW; Ticino F; Chronister CW; Bertholf RL
    Ann Clin Lab Sci; 2000 Jan; 30(1):85-91. PubMed ID: 10678589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of a direct high-capacity target screening approach for urine drug testing using liquid chromatography-time-of-flight mass spectrometry.
    Saleh A; Stephanson NN; Granelli I; Villén T; Beck O
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Nov; 909():6-13. PubMed ID: 23153637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urine screening for drug abuse.
    Lund PK
    J Oslo City Hosp; 1984; 34(11-12):115-22. PubMed ID: 6392496
    [No Abstract]   [Full Text] [Related]  

  • 32. Urine screening for drugs.
    Browne R; Sloan D; Fahy S; Talbot D; O'Connor J
    Br J Psychiatry; 1997 Mar; 170():290. PubMed ID: 9229044
    [No Abstract]   [Full Text] [Related]  

  • 33. Workplace drug testing in Italy: findings about second-stage testing.
    Vignali C; Stramesi C; Morini L; San Bartolomeo P; Groppi A
    Drug Test Anal; 2015 Mar; 7(3):173-7. PubMed ID: 24652693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urine opioid screens may be misleading.
    Rubingh C
    J Pain Palliat Care Pharmacother; 2002; 16(2):103-4. PubMed ID: 14650466
    [No Abstract]   [Full Text] [Related]  

  • 35. Laboratory and clinical evaluation of on-site urine drug testing.
    Beck O; Carlsson S; Tusic M; Olsson R; Franzen L; Hulten P
    Scand J Clin Lab Invest; 2014 Nov; 74(8):681-6. PubMed ID: 25046332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibody urine assay for amphetamines, cocaine and cannabinoids: a pilot study of Mexican athletes.
    Padilla J; Eguíalis MC; Mendoza F; Santos VA; Ojeda P
    Proc West Pharmacol Soc; 2002; 45():191-2. PubMed ID: 12434578
    [No Abstract]   [Full Text] [Related]  

  • 37. False-positive interferences of common urine drug screen immunoassays: a review.
    Saitman A; Park HD; Fitzgerald RL
    J Anal Toxicol; 2014 Sep; 38(7):387-96. PubMed ID: 24986836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A high-sensitivity ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry (UHPLC-HR-TOFMS) method for screening synthetic cannabinoids and other drugs of abuse in urine.
    Sundström M; Pelander A; Angerer V; Hutter M; Kneisel S; Ojanperä I
    Anal Bioanal Chem; 2013 Oct; 405(26):8463-74. PubMed ID: 23954996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Workplace testing of drugs of abuse and psychotropic drugs].
    Mura P; Saussereau E; Brunet B; Goullé JP
    Ann Pharm Fr; 2012 May; 70(3):120-32. PubMed ID: 22655580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparison of the MTP immunoassay with EMIT in blood screening for drugs].
    Käferstein H; Sticht G
    Arch Kriminol; 1998; 202(5-6):165-72. PubMed ID: 10023491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.